These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31189997)

  • 61. Exploring chromosomal abnormalities and genetic changes in uterine smooth muscle tumors.
    Liegl-Atzwanger B; Heitzer E; Flicker K; Müller S; Ulz P; Saglam O; Tavassoli F; Devouassoux-Shisheboran M; Geigl J; Moinfar F
    Mod Pathol; 2016 Oct; 29(10):1262-77. PubMed ID: 27363490
    [TBL] [Abstract][Full Text] [Related]  

  • 62. STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion.
    Subbiah V; McMahon C; Patel S; Zinner R; Silva EG; Elvin JA; Subbiah IM; Ohaji C; Ganeshan DM; Anand D; Levenback CF; Berry J; Brennan T; Chmielecki J; Chalmers ZR; Mayfield J; Miller VA; Stephens PJ; Ross JS; Ali SM
    J Hematol Oncol; 2015 Jun; 8():66. PubMed ID: 26062823
    [TBL] [Abstract][Full Text] [Related]  

  • 63. "Low-grade leiomyosarcoma" and late-recurring smooth muscle tumors of the uterus: a heterogenous collection of frequently misdiagnosed tumors associated with an overall favorable prognosis relative to conventional uterine leiomyosarcomas.
    Veras E; Zivanovic O; Jacks L; Chiappetta D; Hensley M; Soslow R
    Am J Surg Pathol; 2011 Nov; 35(11):1626-37. PubMed ID: 21921786
    [TBL] [Abstract][Full Text] [Related]  

  • 64. From PTEN loss of expression to RICTOR role in smooth muscle differentiation: complex involvement of the mTOR pathway in leiomyosarcomas and pleomorphic sarcomas.
    Gibault L; Ferreira C; Pérot G; Audebourg A; Chibon F; Bonnin S; Lagarde P; Vacher-Lavenu MC; Terrier P; Coindre JM; Aurias A
    Mod Pathol; 2012 Feb; 25(2):197-211. PubMed ID: 22080063
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Differential expression of P16 and P21 in benign and malignant uterine smooth muscle tumors.
    Ünver NU; Acikalin MF; Öner Ü; Ciftci E; Ozalp SS; Colak E
    Arch Gynecol Obstet; 2011 Aug; 284(2):483-90. PubMed ID: 20878171
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clear cell sarcomas of the kidney are characterised by BCOR gene abnormalities, including exon 15 internal tandem duplications and BCOR-CCNB3 gene fusion.
    Wong MK; Ng CCY; Kuick CH; Aw SJ; Rajasegaran V; Lim JQ; Sudhanshi J; Loh E; Yin M; Ma J; Zhang Z; Iyer P; Loh AHP; Lian DWQ; Wang S; Goh SGH; Lim TH; Lim AST; Ng T; Goytain A; Loh AHL; Tan PH; Teh BT; Chang KTE
    Histopathology; 2018 Jan; 72(2):320-329. PubMed ID: 28833375
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Myxoid mesenchymal tumors of uterus: endometrial stromal and smooth muscle tumors, myxoid variant].
    Chesnais AL; Watkin E; Beurton D; Devouassoux-Shisheboran M
    Ann Pathol; 2011 Jun; 31(3):152-8. PubMed ID: 21736994
    [TBL] [Abstract][Full Text] [Related]  

  • 68. HMGIC alterations in smooth muscle tumors of soft tissues and other sites.
    Hisaoka M; Sheng WQ; Tanaka A; Hashimoto H
    Cancer Genet Cytogenet; 2002 Oct; 138(1):50-5. PubMed ID: 12419585
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Clinicopathological study of BCOR rearrangement in high grade endometrial stromal sarcoma].
    Cheng YF; Bai QM; Bi R; Chang B; Huang D; Yu L; Zhou XY; Yang WT; Tu XY
    Zhonghua Bing Li Xue Za Zhi; 2019 Aug; 48(8):604-609. PubMed ID: 31422590
    [No Abstract]   [Full Text] [Related]  

  • 70. Intravenous leiomyomatosis: an unusual intermediate between benign and malignant uterine smooth muscle tumors.
    Ordulu Z; Nucci MR; Dal Cin P; Hollowell ML; Otis CN; Hornick JL; Park PJ; Kim TM; Quade BJ; Morton CC
    Mod Pathol; 2016 May; 29(5):500-10. PubMed ID: 26892441
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Uterine smooth muscle tumors with features suggesting fumarate hydratase aberration: detailed morphologic analysis and correlation with S-(2-succino)-cysteine immunohistochemistry.
    Reyes C; Karamurzin Y; Frizzell N; Garg K; Nonaka D; Chen YB; Soslow RA
    Mod Pathol; 2014 Jul; 27(7):1020-7. PubMed ID: 24309325
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Malignant mesenchymal tumors of the uterus - time to advocate a genetic classification.
    Rommel B; Holzmann C; Bullerdiek J
    Expert Rev Anticancer Ther; 2016 Nov; 16(11):1155-1166. PubMed ID: 27602604
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Patterns of bone morphogenetic protein-2 expression in smooth muscle tumors of the uterine corpus and other uterine tissues.
    Fadare O; Renshaw IL; Liang SX
    Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):352-9. PubMed ID: 21285872
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Primary Renal Sarcomas With BCOR-CCNB3 Gene Fusion: A Report of 2 Cases Showing Histologic Overlap With Clear Cell Sarcoma of Kidney, Suggesting Further Link Between BCOR-related Sarcomas of the Kidney and Soft Tissues.
    Argani P; Kao YC; Zhang L; Bacchi C; Matoso A; Alaggio R; Epstein JI; Antonescu CR
    Am J Surg Pathol; 2017 Dec; 41(12):1702-1712. PubMed ID: 28817404
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The phosphatidylinositol 3' kinase-Akt-mammalian target of rapamycin pathway in smooth muscle tumors of the uterus: selected protein expression patterns and their clinicopathologic implications.
    Fadare O; Renshaw I; Olson SJ; Liang SX
    Int J Gynecol Pathol; 2011 May; 30(3):244-51. PubMed ID: 21464729
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Epithelioid smooth muscle tumors of the uterus do not express CD1a: a potential immunohistochemical adjunct in their distinction from uterine perivascular epithelioid cell tumors.
    Fadare O; Liang SX
    Ann Diagn Pathol; 2008 Dec; 12(6):401-5. PubMed ID: 18995203
    [TBL] [Abstract][Full Text] [Related]  

  • 77. ZC3H7B-BCOR-Rearranged Endometrial Stromal Sarcomas: A Distinct Subset Merits its Own Classification?
    Mansor S; Kuick CH; Lim SL; Quek R; Wong APC; Lim-Tan SK; Lim TYK; Chang KTE
    Int J Gynecol Pathol; 2019 Sep; 38(5):420-425. PubMed ID: 29901520
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immunophenotype-Genotype Correlations in Clear Cell Sarcoma of Kidney-An Evaluation of Diagnostic Ancillary Studies.
    Kenny C; Grehan D; Ulas M; Banga GB; Coulomb A; Vokuhl C; O'Sullivan MJ
    Pediatr Dev Pathol; 2020; 23(5):345-351. PubMed ID: 32364435
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Immunohistochemistry (Ki-67 and p53) as a tool in determining malignancy in smooth muscle neoplasms (exemplified by a myxoid leiomyosarcoma of the uterus).
    Sprogøe-Jakobsen S; Hølund B
    APMIS; 1996 Oct; 104(10):705-8. PubMed ID: 8980620
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Endometrial stromal tumors: an update on a group of tumors with a protean phenotype.
    Oliva E; Clement PB; Young RH
    Adv Anat Pathol; 2000 Sep; 7(5):257-81. PubMed ID: 10976906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.